Full Text View
Tabular View
No Study Results Posted
Related Studies
Trazodone for Sleep Disorders in Alzheimer's Disease
This study has been completed.
Study NCT01142258   Information provided by Brasilia University Hospital

First Received on June 9, 2010.   Last Updated on October 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sleep
Sleep Disorders
Insomnia
Alzheimer's Disease
Additional conditions recognized in this trial
Alzheimer Disease
Parasomnias
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Neurologic Manifestations
Signs and Symptoms
Sleep Disorders, Intrinsic
Tauopathies
Interventions listed in this trial
Trazodone
Placebo
More general drug interventions related to this trial
Anti-Anxiety Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Central Nervous System Depressants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Brasilia University Hospital
Universidade Federal do Paraná


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services